Inhibition of Protein Farnesylation Arrests Adipogenesis and Affects PPARγ Expression and Activation in Differentiating Mesenchymal Stem Cells
2007

Inhibition of Protein Farnesylation Affects Fat Cell Development

publication Evidence: moderate

Author Information

Author(s): Daniel Rivas, Akter Rahima, Gustavo Duque

Primary Institution: Lady Davis, Institute for Medical Research

Hypothesis

Protein farnesylation is required for PPARγ2 expression and activation, and therefore for the differentiation of human mesenchymal stem cells (MSCs) into adipocytes.

Conclusion

Inhibition of protein farnesylation arrests the adipogenic differentiation of MSCs and affects PPARγ expression and activity.

Supporting Evidence

  • Inhibition of farnesylation led to changes in cell phenotype and reduced fat droplet production.
  • Cells treated with the inhibitor showed nuclear changes compatible with blebbing.
  • The study demonstrated that farnesylation is essential for the activation of proteins involved in adipogenesis.

Takeaway

This study found that blocking a specific process in cells stops them from turning into fat cells, which is important for understanding fat development in the body.

Methodology

Human MSCs were induced to differentiate into adipocytes and treated with a farnesylation inhibitor, with effects assessed through staining and protein expression analysis.

Limitations

Pharmacological inhibition of farnesylation could affect many proteins required in adipogenesis.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2007/81654

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication